|
No records
|
|
697 |
57189373134 |
Sally Aman Nasution |
Dr.dr. Sally Aman Nasution, Sp.PD-KKV. |
Departemen Ilmu Penyakit Dalam |
Ilmu Penyakit Dalam (Sp-2) |
Thrombocytopenia as a prognostic marker in COVID-19 patients: Diagnostic test accuracy meta-analysis |
Pranata R., Lim M.A., Yonas E., Huang I., Nasution S.A., Setiati S., Alwi I., Kuswardhani R.A.T. |
Epidemiology and Infection |
6 |
Q2 |
|
|
|
542 |
12776850800 |
Irsan Hasan |
dr. Irsan Hasan, Sp.PD-KGEH. |
Departemen Ilmu Penyakit Dalam |
Ilmu Penyakit Dalam (Sp-2) |
Overall Survival of Hepatocellular Carcinoma Patients Underwent Radiofrequency Ablation (RFA) Treatment: a Retrospective Cohort Study from Two Referral Hospitals in Indonesia |
Sulaiman A.S., Gani R.A., Hasan I., Lesmana C.R.A., Kurniawan J., Jasirwan C.O.M., Kalista K.F., Nababan S.H.H., Aprilicia G., Lesmana L.A. |
Journal of Gastrointestinal Cancer |
|
Q3 |
|
|
|
705 |
12776850800 |
Irsan Hasan |
dr. Irsan Hasan, Sp.PD-KGEH. |
Departemen Ilmu Penyakit Dalam |
Ilmu Penyakit Dalam (Sp-2) |
SGLT2 inhibitors for improving hepatic fibrosis and steatosis in non-alcoholic fatty liver disease complicated with type 2 diabetes mellitus: a systematic review |
Dwinata M., Putera D.D., Hasan I., Raharjo M. |
Clinical and Experimental Hepatology |
|
Q4 |
|
|
|
661 |
23475336100 |
Pradana Soewondo |
Prof. Dr. dr. Pradana Soewondo, SpPD-KEMD |
Departemen Ilmu Penyakit Dalam |
Ilmu Penyakit Dalam (Sp-2) |
Autologous Bone-Marrow vs. Peripheral Blood Mononuclear Cells Therapy for Peripheral Artery Disease in Diabetic Patients |
Yunir E., Kurniawan F., Rezaprasga E., Wijaya I.P., Suroyo I., Matondang S., Irawan C., Soewondo P. |
International Journal of Stem Cells |
|
Q4 |
|
|
|
711 |
23498394800 |
Leonard Nainggolan |
dr. Leonard Nainggolan, Sp.PD-KPTI. |
Departemen Ilmu Penyakit Dalam |
Ilmu Penyakit Dalam (Sp-2) |
Circulation of various dengue serotypes in a community-based study in Jakarta, Indonesia |
Dewi B.E., Nainggolan L., Sudiro T.M., Chenderawasi S., Goentoro P.L., Sjatha F. |
Japanese Journal of Infectious Diseases |
1 |
Q3 |
|
|
|
701 |
24336854300 |
Imam Subekti |
Prof. Dr. dr. Imam Subekti, SpPD-KEMD |
Departemen Ilmu Penyakit Dalam |
Ilmu Penyakit Dalam (Sp-2) |
Serum TSH level as predictor of Graves' disease recurrence following antithyroid drug withdrawal: A systematic review |
Subekti I., Kartiko G.J., Suhardi Z.F., Muhadi, Wisnu W. |
PLoS ONE |
1 |
Q1 |
|
|
|
661 |
28767651600 |
Cosphiadi Irawan |
Dr. dr. Cosphiadi Irawan, SpPD-KHOM |
Departemen Ilmu Penyakit Dalam |
Ilmu Penyakit Dalam (Sp-2) |
Autologous Bone-Marrow vs. Peripheral Blood Mononuclear Cells Therapy for Peripheral Artery Disease in Diabetic Patients |
Yunir E., Kurniawan F., Rezaprasga E., Wijaya I.P., Suroyo I., Matondang S., Irawan C., Soewondo P. |
International Journal of Stem Cells |
|
Q4 |
|
|
|
609 |
36056341600 |
Dante Saksono Harbuwono |
dr. Dante Saksono Harbuwono, Sp.PD., Ph.D. |
Departemen Ilmu Penyakit Dalam |
Ilmu Penyakit Dalam (Sp-2) |
ADA Diabetes Risk Test Adaptation in Indonesian Adult Populations: Can It Replace Random Blood Glucose Screening Test? |
Harbuwono D.S., Mokoagow M.I., Magfira N., Helda H. |
Journal of Primary Care and Community Health |
|
Q2 |
|
|
|
487 |
36520254800 |
Em Yunir |
Dr.dr. Em Yunir, SpPD-KEMD |
Departemen Ilmu Penyakit Dalam |
Ilmu Penyakit Dalam (Sp-2) |
Hyaluronic Acid Accelerates VEGF and PDGF Release from Advance Platelet Rich Fibrin in Diabetic Foot Ulcer |
Kartika R.W., Alwi I., Suyatna F.D., Sandra F., Yunir E., Waspadji S., Immanuel S., Silalahi T., Sungkar S., Rachmat J., Bardosono S., Reksodiputro M.H. |
Indonesian Biomedical Journal |
|
Q4 |
|
|
|
517 |
36520254800 |
Em Yunir |
Dr.dr. Em Yunir, SpPD-KEMD |
Departemen Ilmu Penyakit Dalam |
Ilmu Penyakit Dalam (Sp-2) |
Effect of angiotensin receptor blocker and angiotensin converting enzyme inhibitor on kidney function and blood potassium level in indonesian type 2 diabetes mellitus with hypertension: A three-month cohort study |
Puspita F.M., Yunir E., Agustina P.S., Sauriasari R. |
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy |
|
Q2 |
|
|
